Prosecution Insights
Last updated: April 19, 2026

Axsome Therapeutics Inc.

6 pending office actions

Portfolio Summary

6
Total Pending OAs
2
Final Rejections
4
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
19236838 PHARMACEUTICAL COMPOSITIONS COMPRISING MELOXICAM HOWELL, THEODORE R 1628 Final Rejection Jun 12, 2025
19169261 PHARMACEUTICAL COMPOSITIONS COMPRISING MELOXICAM HOWELL, THEODORE R 1628 Non-Final OA Apr 03, 2025
18671931 USE OF REBOXETINE TO TREAT NARCOLEPSY CHANDRAKUMAR, NIZAL S 1625 Final Rejection May 22, 2024
18512551 PHARMACEUTICAL COMPOSITIONS COMPRISING MELOXICAM HOWELL, THEODORE R 1628 Non-Final OA Nov 17, 2023
18503996 PHARMACEUTICAL COMPOSITIONS COMPRISING MELOXICAM HOWELL, THEODORE R 1628 Non-Final OA Nov 07, 2023
18366992 PHARMACEUTICAL COMPOSITIONS COMPRISING MELOXICAM HOWELL, THEODORE R 1628 Non-Final OA Aug 08, 2023

Managing Axsome Therapeutics Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month